Johns Hopkins Bloomberg School of Public Health

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Johns Hopkins Bloomberg School of Public Health sits in the top decile of US sponsors by registered trial count (#159 of 15,742 sponsors by registered trial count).

187 total trials 26 currently recruiting 150 completed top decile by trial count

Johns Hopkins Bloomberg School of Public Health: 187 sponsored US clinical trials, 26 recruiting.

Johns Hopkins Bloomberg School of Public Health sponsors 187 registered US clinical trials on ClinicalTrials.gov, 26 of them currently recruiting, and 150 completed. 15 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Substance Use, with 6 trials.

Top-decile sponsor footprint

Johns Hopkins Bloomberg School of Public Health ranks in the top decile of sponsors by registered trial count (#159 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 83/100

150 of 154 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

187 total, page 3 of 4

COMPLETED NA

Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist

NCT02895243

COMPLETED NA

Evaluation of Respecting the Circle of Life on Pregnancy Prevention Outcomes Among American Indian Adolescents

NCT02904629

COMPLETED NA

Effects of Energy Drinks

NCT02727920

COMPLETED NA

Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A

NCT02773446

TERMINATED NA

Hemodialysis-based Interventions to Preserve Cognitive Function

NCT02697942

COMPLETED Phase 3

Apathy in Dementia Methylphenidate Trial 2

NCT02346201

COMPLETED NA

Enhancing Safe Sleep Practices of Urban Low-Income Mothers

NCT03070639

COMPLETED NA

Trial of an Adapted STD Screening and Risk Reduction Intervention

NCT02513225

TERMINATED NA

Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi

NCT02499172

COMPLETED NA

Engaging Tribal Policy Makers to Improve the Food and Physical Activity Environments in American Indian Communities

NCT02803853

COMPLETED

Combining Data Sources to Identify Effect Moderation for Personalized Mental Health

NCT05267873

COMPLETED Phase 2

Efficacy of Rifaximin in Preventing Campylobacteriosis

NCT02280044

COMPLETED NA

Common Engagement Strategies (Common Factors) for Childhood Anxiety

NCT02441569

COMPLETED NA

Safety in Seconds 2.0: An App to Increase Car Seat Use

NCT02345941

COMPLETED NA

Evaluation of an Entrepreneurship Program for American-Indian Youth

NCT02157493

COMPLETED NA

Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes

NCT02222909

COMPLETED Phase 4

Immune and Hormone Response to Influenza Vaccine

NCT01978262

COMPLETED NA

Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV

NCT01892566

COMPLETED NA

Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care

NCT01941108

COMPLETED

Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment

NCT02637622

COMPLETED

Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling

NCT02637609

COMPLETED NA

Extension Study of the Family Spirit Program

NCT01910701

COMPLETED NA

A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives

NCT01935440

COMPLETED

Gastroparesis Registry 2

NCT01696747

COMPLETED NA

Maintenance of Recommended Sodium Intake

NCT01615159

COMPLETED NA

Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors

NCT01613430

COMPLETED NA

Multi-level Communications and Access Strategies to Improve the Food Environment

NCT02279849

COMPLETED NA

Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

NCT01522248

COMPLETED NA

B'More Healthy; Communities for Kids (BHCK)

NCT02181010

COMPLETED NA

Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth

NCT01910727

COMPLETED NA

Social Networks and Prevention for HIV Care and Prevention

NCT01800721

COMPLETED Phase 3

Tinnitus Retraining Therapy Trial

NCT01177137

COMPLETED NA

Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis

NCT01030341

COMPLETED NA

Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth

NCT01910714

COMPLETED Phase 2

Apathy in Dementia Methylphenidate Trial (ADMET)

NCT01117181

COMPLETED

NAFLD Pediatric Database 2

NCT01061684

COMPLETED

Study of Oral Papillomavirus In Teens and Twenties

NCT00994019

COMPLETED

Impact of PCV on Disease and Colonization Among Native American Communities

NCT01083459

COMPLETED

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2

NCT01030484

COMPLETED

Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time

NCT01342978

COMPLETED NA

Substituting Mushrooms for Meat to Control Body Weight

NCT01177085

COMPLETED NA

Stress, Dietary Lapse and Weight Loss Among Adults With Type 2 Diabetes

NCT00831194

COMPLETED Phase 1

Low-dose Challenge Model With Enterotoxigenic E Coli

NCT00844493

COMPLETED Phase 4

MethaCholine Bronchoprovocation Study (MeCIS)

NCT00705341

COMPLETED NA

Impact of Chlorhexidine Cleansing on Bacteria Colonizing the Umbilical Cord of Infants in Bangladesh

NCT00719329

COMPLETED Phase 3

A Trial of Group Versus Individual Family Planning Counseling in Ghana

NCT00814411

COMPLETED Phase 3

Antenatal Micronutrient Supplementation and Infant Survival

NCT00860470

COMPLETED Phase 2

Neighborhoods, Networks, Depression, and HIV Risk

NCT01380613

COMPLETED Phase 1

Dose-Finding Study of CS19 Expressing ETEC Challenge Strains

NCT00564863

COMPLETED NA

Effectiveness of Quaker Complete Nutrition Supplements for Malnourished Adults

NCT00523900

← Previous Page 3 of 4 Next →

Phase Distribution

PhaseTrial count
Phase 1 8
Phase 2 8
Phase 3 9
Phase 4 6

What is open in the Johns Hopkins Bloomberg School of Public Health pipeline

26 recruiting of 187 indexed (14% open); 150 completed (80%).

Phase mix: 15 late (III/IV) vs 16 early (I/II) (balanced across stages).

Top condition: Substance Use (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Johns Hopkins Bloomberg School of Public Health: open-pipeline peers nationwide

Peers matched on 187 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Johns Hopkins Bloomberg School of Public Health sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 12%13%14%15%16% Total trials Recruiting share Johns Hopkins Bloomberg School of Public HealthArizona State UniversityNationwide Children's HospitalVanderbilt-Ingram Cancer CenterBoston UniversityMilton S. Hershey Medical CenterUniversity of CincinnatiSeattle Institute for Biomedical and Clinical ResearchUniversity of Illinois at Urbana-Champaign
Johns Hopkins Bloomberg School of Public Health sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Johns Hopkins Bloomberg School of Public Health sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 187 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Johns Hopkins Bloomberg School of Public Health page

187 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins Bloomberg School of Public Health or any single study.

  • 26 of Johns Hopkins Bloomberg School of Public Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Substance Use is the condition Johns Hopkins Bloomberg School of Public Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Substance Use trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Johns Hopkins Bloomberg School of Public Health pipeline card: 187 registered trials from official public datasets.Report a data error.